ClinicalTrials.Veeva

Menu

The EMBER Trial for Weight Management Engagement

VA Office of Research and Development logo

VA Office of Research and Development

Status

Completed

Conditions

Obesity

Treatments

Behavioral: Control
Behavioral: EMBER

Study type

Interventional

Funder types

Other U.S. Federal agency

Identifiers

NCT05424081
IIR 19-422

Details and patient eligibility

About

This study will test whether EMBER, a self-help tool to increase weight loss treatment engagement, helps veterans engage in Veterans Health Administration (VHA) weight management programs. Participants will be randomly assigned to receive EMBER or a list of weight management programs (the control group). They will answer questions about health beliefs and behaviors and share information from their medical record at the start of the study, 2-months after the start of the study, and 6-months after the start of the study. Participants will receive compensation for each of these contacts. Participants will also receive a reminder call 10 days after they enroll in the study. All study contacts will be over the phone. The main hypothesis is that people who receive EMBER will be more likely to use VHA weight management programs than people in the control group.

Full description

Background Almost 40% of veterans using the Veterans Health Administration (VHA) have obesity. However, few patients use VHA's effective weight management programs. This study tests the effectiveness of EMBER, a self-directed tool with the goal of Enhancing Motivation for Better Engagement and Reach (EMBER) for weight management. It is available in paper and digital formats. EMBER is not a weight management program, instead it engages veterans in existing programs by informing and guiding choices about weight management.

Specific Aims

  1. Assess whether veterans randomized to EMBER are more likely to have any weight management engagement at 2-month follow-up (per electronic medical record data supplemented with self-report) compared to those randomized to the control arm (information sheet listing available programs). (Primary Outcome)
  2. Assess whether veterans randomized to EMBER have greater weight management program retention, weight management behaviors (e.g., physical activity), weight loss, and quality of life gains at 6-month follow-up compared to those randomized to the control arm. (Secondary Outcomes)
  3. Assess factors likely to affect EMBER's implementation. Preliminary implementation outcomes will be assessed via RE-AIM (Reach, Effectiveness, Implementation) and the Proctor et al. implementation outcomes framework (Acceptability, Appropriateness, Costs, Fidelity). (Implementation Outcomes)

Methodology Randomized two site Hybrid Type 1 Effectiveness-Implementation Trial among veteran primary care patients with obesity in VA. Participants (N=470) will be randomized to EMBER or a control condition consisting of a list of available weight management programs. Logistic regressions will be used to assess Aims 1 and 2. Aim 3 results are descriptive.

Enrollment

470 patients

Sex

All

Ages

18 to 79 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Veteran using primary care at VA Palo Alto or Houston in prior year
  • BMI greater than or equal to 30 kg/m2

Exclusion criteria

  • Age 80 or older
  • Documentation of a suicide attempt in the past 30 days
  • Hospitalization in the past 30 days
  • Documentation or other evidence of cognitive impairment
  • VA weight management program use in past 2 years
  • Self-report from potential participant that they will not be in town for the majority of the 2 months following baseline
  • Self-report from potential participant they plan to leave VA Palo Alto or Houston within the next 6 months
  • Under age 18

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

470 participants in 2 patient groups

EMBER
Experimental group
Description:
Self-help tool to increase weight management engagement
Treatment:
Behavioral: EMBER
Control
Active Comparator group
Description:
List of treatments
Treatment:
Behavioral: Control

Trial documents
1

Trial contacts and locations

2

Loading...

Central trial contact

Jessica Y Breland, PhD MS BA; Marnelle Cruz, BA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems